Monascus secondary metabolites monascin and ankaflavin inhibit activation of RBL-2H3 Cells

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 1, 2015, Pages 192-199

  Chang, Yu Ying ^a   Hsu, Wei Hsuan ^a   Pan, Tzu Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

allergy; ankaflavin; mast cell; monascin; PPAR

Indexed keywords

ALLERGIES; CELLS; CHEMICAL ACTIVATION; CYTOLOGY; DISEASES; MEDICAL APPLICATIONS; METABOLITES;

ANKAFLAVIN; ANTI-INFLAMMATORIES; IMMUNOMODULATORY EFFECTS; MAST CELLS; MONASCIN; MONASCUS-FERMENTED PRODUCTS; SECONDARY METABOLITES; SIGNALING MOLECULES;

CELL SIGNALING;

MONASCUS;

ANKAFLAVIN; ANTIINFLAMMATORY AGENT; FUSED HETEROCYCLIC RINGS; MONASCIN; RIBOFLAVIN DERIVATIVE;

ANIMAL; ASTHMA; CELL LINE; CHEMISTRY; DRUG EFFECTS; FERMENTATION; HUMAN; IMMUNOLOGY; MAST CELL; METABOLISM; MICROBIOLOGY; MONASCUS; RAT; RICE; SECONDARY METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CELL LINE; FERMENTATION; FLAVINS; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; MAST CELLS; MONASCUS; ORYZA SATIVA; RATS; SECONDARY METABOLISM;

EID: 84921053227     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf504013n     Document Type: Article

References (33)

1. Parham, P. Over-Reaction of the Immune System. The Immune System, 3 rd ed.; Garland Science, Taylor and Francis Group: London, UK, 2009; pp 366-385.
2. Itoh, T.; Ohguchi, K.; Iinuma, M.; Nozawa, Y.; Akao, Y. Inhibitory effects of polymethoxy flavones isolated from Citrus reticulate on degranulation in rat basophilic leukemia RBL-2H3: enhanced inhibition by their combination Bioorg. Med. Chem. 2008, 16, 7592-7598
3. Averbeck, M.; Gebhardt, C.; Emmrich, F.; Treudler, R.; Simon, J. C. Immunologic principles of allergic disease J. Dtsch. Dermatol. Ges. 2007, 5, 1015-1028
4. Gordon, J. R.; Galli, S. J. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses J. Exp. Med. 1991, 174, 103-107
5. Lee, B. H.; Hsu, W. H.; Chang, Y. Y.; Kuo, H. F.; Hsu, Y. W.; Pan, T. M. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo Free Radical Biol. Med. 2012, 53, 2008-2016
6. C. P; Lin, Y. L.; Huang, P. H.; Tsai, H. S.; Chen, Y. H. Inhibition of endothelial adhesion molecule expression by Monascus purpureus -fermented rice metabolites, monacolin K, ankaflavin, and monascin J. Sci. Food Agric. 2011, 91, 1751-1758
7. Hsu, W. H.; Lee, B. H.; Li, C. H.; Hsu, Y. W.; Pan, T. M. Monascin and AITC attenuate methylglyoxal-induced PPARγ phosphorylation and degradation through inhibition of the oxidative stress/PKC pathway depending on Nrf2 activation J. Agric. Food Chem. 2013, 61, 5996-6006
8. Hsu, W. H.; Lee, B. H.; Chang, Y. Y.; Hsu, Y. W.; Pan, T. M. A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia Toxicol. Appl. Pharmacol. 2013, 272, 842-851
9. Lee, B. H.; Hsu, W. H.; Huang, T.; Chang, Y. Y.; Hsu, Y. W.; Pan, T. M. Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated Wistar rats J. Agric. Food Chem. 2013, 61, 1288-1298
10. Hsu, W. H.; Lee, B. H.; Huang, Y. C.; Hsu, Y. W.; Pan, T. M. Ankaflavin, a novel Nrf-2 activator for attenuating allergic airway inflammation Free Radical Biol. Med. 2012, 53, 1643-1651
11. Lee, B. H.; Hsu, W. H.; Huang, T.; Chang, Y. Y.; Hsu, Y. W.; Pan, T. M. Monascin improves diabetes and dyslipidemia by regulating PPARγ and inhibiting lipogenesis in fructose-rich diet-induced C57BL/6 mice Food Funct. 2013, 4, 950-959
12. Hsu, W. H.; Lee, B. H.; Chang, Y. Y.; Hsu, Y. W.; Pan, T. M. A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia Toxicol. Appl. Pharmacol. 2013, 272, 842-851
13. Shi, Y. C.; Liao, V. H.; Pan, T. M. Monascin from red mold dioscorea as a novel antidiabetic and antioxidative stress agent in rats and Caenorhabditis elegans Free Radical Biol. Med. 2012, 52, 109-117
14. Hsu, W. H.; Lee, B. H.; Hsu, Y. W.; Pan, T. M. Inhibition of Th2 cytokine production in T cells by monascin via PPAR-γ activation J. Agric. Food Chem. 2013, 61, 8126-8133
15. Martinkova, L.; Patakova-Juzlova, P.; Krent, V.; Kucerova, Z.; Havlicek, V.; Olsovsky, P.; Hovorka, O.; Rihova, B.; Vesely, D.; Vesela, D.; Ulrichova, J.; Prikrylova, V. Biological activities of oligoketide pigments of Monascus purpureus Food Addit. Contam. 1999, 16, 15-24
16. Hsu, W. H.; Lee, B. H.; Pan, T. M. Monascin attenuates oxidative stress-mediated lung inflammation via peroxisome proliferator-activated receptor-gamma (PPARγ) and nuclear factor-erythroid 2 related factor 2 (Nrf-2) modulation J. Agric. Food Chem. 2014, 62, 5337-5344
17. Wagner, E. R.; He, B. C.; Chen, L.; Zuo, G. W.; Zhang, W.; Shi, Q.; Luo, Q.; Luo, X.; Liu, B.; Luo, J.; Rastegar, F.; He, C. J.; Hu, Y.; Boody, B.; Luu, H. H.; He, T. C.; Deng, Z. L.; Haydon, R. C. Therapeutic implications of PPAR in human osteosarcoma PPAR Res. 2010, 956427
18. Szeles, L.; Torocsik, D.; Nagy, L. PPARγ in immunity and inflammation: cell types and diseases Biochim. Biophys. Acta 2007, 1771, 1014-1030
19. Hsu, W. H.; Lee, B. H.; Hsu, Y. W.; Pan, T. M. Peroxisome proliferator-activated receptor-γ activators monascin and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycation end products signaling J. Agric. Food Chem. 2013, 61, 6873-6879
20. Slater, S. J.; Kelly, M. B.; Taddeo, F. J.; Rubin, E.; Stubbs, C. D. Evidence for discrete diacylglycerol and phorbol ester activator sites on protein kinase C. Differences in effects of 1-alkanol inhibition, activation by phosphatidylethanolamine and calcium chelation J. Biol. Chem. 1994, 269, 17160-17165
21. Liu, C.; Hermann, T. E. Characterization of ionomycin as a calcium ionophore J. Biol. Chem. 1978, 253, 5892-5894
22. Karra, L.; Levi-Schaffer, F. Down-regulation of mast cell responses through ITIM containing inhibitory receptors Adv. Exp. Med. Biol. 2011, 716, 143-159
23. Blank, U.; Rivera, J. Assays for regulated exocytosis of mast cell granules. Curr. Protoc. Cell Biol. 2006, Chapter 15, Unit 15-11.
24. Vo, T. S.; Kong, C. S.; Kim, S. K. Inhibitory effects of chitooligosaccharides on degranulation and cytokine generation in rat basophilic leukemia RBL-2H3 cells Carbohydr. Polym. 2011, 84, 649-655
25. Han, E. H.; Hwang, Y. P.; Kim, H. G.; Park, J. H.; Choi, J. H.; Im, J. H.; Khanal, T.; Park, B. H.; Yang, J. H.; Choi, J. M.; Chun, S. S.; Seo, J. K.; Chung, Y. C.; Jeong, H. G. Ethyl acetate extract of Psidium guajava inhibits IgE-mediated allergic responses by blocking FcεRI signaling Food Chem. Toxicol. 2011, 49, 100-108
26. Inoue, T.; Suzuki, Y.; Yoshimaru, T.; Ra, C. Reactive oxygen species produced up- or downstream of calcium influx regulate proinflammatory mediator release from mast cells: role of NADPH oxidase and mitochondria Biochim. Biophys. Acta 2008, 83, 789-802
27. Okuyama, K.; Yamashita, M.; Kitabatake, Y.; Kawamura, S.; Takayanagi, M.; Ohno, I. Ciglitazone inhibits the antigen-induced leukotrienes production independently of PPARγ in RBL-2H3 mast cells Eur. J. Pharmacol. 2005, 521, 21-28
28. Sugiyama, H.; Nonaka, T.; Kishimoto, T.; Komoriya, K.; Tsuji, K.; Nakahata, T. Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation Eur. J. Immunol. 2000, 30, 3363-3370
29. Abdel-Raheem, I. T.; Hide, I.; Yanase, Y.; Shigemoto-Mogami, Y.; Sakai, N.; Shirai, Y.; Saito, N.; Hamada, F. M.; El-Mahdy, N. A.; El-Mahdy, N. A.; Sokar, S. S.; Nakata, Y. Protein kinase C-α mediates TNF release process in RBL-2H3 mast cells Br. J. Pharmacol. 2005, 145, 415-423
30. Zhang, C.; Baumgartner, R. A.; Yamada, K.; Beaven, M. A. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases J. Biol. Chem. 1997, 272, 13397-13402
31. Hide, I.; Toriu, N.; Nuibe, T.; Inoue, A.; Hide, M.; Yamamoto, S.; Nakata, Y. Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-α release, transcription, and degranulation J. Immunol. 1997, 159, 2932-2940
32. Berger, W.; Hampel, F.; Bernstein, J.; Shah, S.; Sacks, H.; Meltzer, E. O. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis Ann. Allergy Asthma Immunol. 2006, 97, 375-381
33. Corren, J.; Storms, W.; Bernstein, J.; Berger, W.; Nayak, A.; Sacks, H. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis Clin. Ther. 2005, 27, 543-553